Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function
- PMID: 26188532
- DOI: 10.1016/j.atherosclerosis.2015.06.059
Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function
Abstract
Objective: To evaluate the apparent association of human immunodeficiency virus (HIV) infection, antiretroviral therapy (ART), and protease inhibitor (PI) exposure with the functional and structural markers of vasculature.
Methods: A meta-analysis of the relationship between HIV infection, ART, and PI exposure and the functional and structural markers of vasculature. A systematic literature search was performed electronically using specific eligibility criteria. Weighted mean difference (WMD) and corresponding 95% confidence interval (CI) were calculated and combined appropriately.
Results: Fifty-seven articles were included with nine different outcomes. Compared with HIV-negative patients, HIV-positive patients demonstrated significant elevated intima-media thickness (IMT) (WMD (95% CI) = 0.042 (0.028-0.057)), increased pulse wave velocity (PWV) (0.538 (0.283-0.792)), and reduced flow-mediated vasodilation (FMD) (-2.049 (-2.806 to -1.293)). Elevated IMT was observed in HIV patients receiving ART when compared with those naïve to ART in the 20- to 40-year-old age group (0.078 (0.033-0.123)), the >40-year-old age group (0.038 (0.018-0.057)), and the group comprising >50% males (0.070 (0.041-0.099)). In addition, ART resulted in an increased PWV in HIV patients receiving ART in the group with >50% male proportion (0.628 (0.405-0.851)). HIV patients exposed to PI showed a significant trend toward elevated IMT (0.033 (0.007-0.058)) and increased PWV (0.264 (0.118-0.410)) compared with those without PI exposure.
Conclusions: The atherosclerotic process was accentuated by elevated IMT, increased PWV, and reduced FMD under condition of HIV infection. Comparison of ART-receiving with ART-naïve patients showed a significant trend toward elevated IMT and increased PWV, especially under treatment with PI-containing drugs.
Keywords: Antiretroviral therapy; Atherosclerotic process; Human immunodeficiency virus; Meta-analysis; Protease inhibitor; The markers of arterial structure and function.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease.Clin Sci (Lond). 2008 Sep;115(6):189-96. doi: 10.1042/CS20070353. Clin Sci (Lond). 2008. PMID: 18251713
-
Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.J Biomech. 2016 Sep 6;49(13):2584-2592. doi: 10.1016/j.jbiomech.2016.05.018. Epub 2016 May 21. J Biomech. 2016. PMID: 27270208
-
Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity.Atherosclerosis. 2013 Dec;231(2):365-70. doi: 10.1016/j.atherosclerosis.2013.09.028. Epub 2013 Oct 16. Atherosclerosis. 2013. PMID: 24267253
-
[HIV infection, antiretroviral therapy, and endothelium].Herz. 2005 Sep;30(6):472-80. doi: 10.1007/s00059-005-2740-3. Herz. 2005. PMID: 16170677 Review. German.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
Cited by
-
Cytomegalovirus may influence vascular endothelial health in Indonesian HIV-infected patients after 5 years on ART.AIDS Res Ther. 2021 Nov 11;18(1):83. doi: 10.1186/s12981-021-00410-7. AIDS Res Ther. 2021. PMID: 34763708 Free PMC article.
-
HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.Curr HIV/AIDS Rep. 2018 Jun;15(3):233-244. doi: 10.1007/s11904-018-0400-5. Curr HIV/AIDS Rep. 2018. PMID: 29752699 Free PMC article. Review.
-
Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.Curr Cardiol Rev. 2018 Mar 14;14(1):25-41. doi: 10.2174/1573403X13666171129170046. Curr Cardiol Rev. 2018. PMID: 29189172 Free PMC article. Review.
-
The Relationship Between Cancer and Functional and Structural Markers of Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2022 May 4;9:849538. doi: 10.3389/fcvm.2022.849538. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35600484 Free PMC article.
-
Assessment of Cardiovascular Risk and Arterial Stiffness in Patients With Human Immunodeficiency Virus.Cureus. 2023 Jul 12;15(7):e41784. doi: 10.7759/cureus.41784. eCollection 2023 Jul. Cureus. 2023. PMID: 37575811 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous